アジア太平洋の脳深部刺激療法市場の2030年までの予測- 地域別分析- 製品、用途、エンドユーザー別

アジア太平洋の脳深部刺激療法市場は、2022年の9,835万米ドルから2030年には1億8,804万米ドルに成長すると予測されています。2022年から2030年までのCAGRは8.4％と推定されます。

深部脳刺激における技術の進歩と承認がアジア太平洋の脳深部刺激療法市場を牽引

ロボット移植、マルチ対象刺激、微小電極設計の改良、充電式パルス発生器、個別化された対象プログラミングなどは、脳深部刺激療法（DBS）における技術進歩のひとつです。これらの進歩により、DBS装置は従来の方法と比べて副作用が少なく、パーキンソン病患者の有効性と症状緩和が改善されています。アボット社のInfinity Deep Brain Stimulation Systemは、患者の症状管理を支援する技術的に進歩した新しいDBSです。これは、効率的で個別化された治療管理を提供し、副作用のリスクを低減した初のワイヤレスiOSソフトウェアDBSモバイルプラットフォームです。2020年2月に発表されたMGM医療のプレスリリースによると、タミル・ナードゥ州のMGM医療は、強迫性障害（OCD）に対して初の脳深部刺激療法（DBS）を実施しました。したがって、DBSの技術的進歩は、予測期間中にアジア太平洋の深部脳刺激市場に機会を創出すると期待されています。

アジア太平洋の脳深部刺激療法市場概要

中国は世界最大の高齢者人口を抱える国です。The Lancetに掲載された「China's Aging Population：Crisis or Opportunity?"（中国の高齢化：危機か機会か）と題されたLancet誌に掲載された研究によると、2019年の中国の60歳以上の高齢者は2億5,400万人でした。2040年までには、この数は4億200万人に増加し、人口の28%に達すると予想されています。このような変化は、非伝染性疾患のリスクと負担が増加し、医療社会保障制度への需要も増加するため、中国の公衆衛生に重大な影響を及ぼします。パーキンソン病（PD）は、中国で一般的な神経変性疾患です。ChinaDailyによると、2023年2月現在、中国には約400万人のパーキンソン病患者がおり、65歳以上の1.7％がパーキンソン病と診断されています。Journal of Health, Population, and Nutritionに掲載された研究によると、中国のアルツハイマー病患者数は600万人で、65歳、75歳、85歳の認知症率はそれぞれ5％、11.5％、30％です。視床下核（STN）の脳深部刺激（DBS）はパーキンソン病（PD）の治療に有効です。DBSハードウェアの進歩に伴い、研究者たちはいくつかの新しいプログラミング技術を開発し、そのうち遠隔プログラミングは中国で広く用いられています。2018年以降、私たちはPINS製品（PINS Medical, Ltd.、中国北京）を用いてPDを患う患者の遠隔プログラミングを行っています。進行したパーキンソン病患者（15年以上の時間的視野）にとって、DBSは非常に有効な治療選択肢であると考えられています。しかし、DBSは他の先進国とは異なり、保険が適用されない場合、患者にとって大きな経済的負担となります。中国では、手術費用は主に患者の健康保険でカバーされるが、DBSハードウェアの費用は部分的にしかカバーされないため、同国の市場成長を妨げる可能性があります。

アジア太平洋の脳深部刺激療法市場の収益と2030年までの予測（金額）

アジア太平洋の脳深部刺激療法市場のセグメンテーション

アジア太平洋の脳深部刺激療法市場は、製品、用途、エンドユーザー、国に区分されます。

製品別では、アジア太平洋の脳深部刺激療法市場は、シングルチャネル深部脳刺激装置、デュアルチャネル深部脳刺激装置、ソフトウェアとアクセサリーに区分されます。2022年には、デュアルチャネル深部脳刺激装置セグメントがアジア太平洋の脳深部刺激療法市場で最大のシェアを記録しました。

用途別では、アジア太平洋の脳深部刺激療法市場は、パーキンソン病、振戦、ジストニア、てんかん、アルツハイマー病、その他に区分されます。2022年には、パーキンソン病分野がアジア太平洋の脳深部刺激療法市場で最大のシェアを記録しました。

エンドユーザー別に見ると、アジア太平洋の脳深部刺激療法市場は、病院、神経科クリニック、外来手術センター、その他に区分されます。2022年には、病院セグメントがアジア太平洋の脳深部刺激療法市場で最大のシェアを記録しました。

国別に見ると、アジア太平洋の脳深部刺激療法市場は、中国、日本、インド、韓国、オーストラリア、その他のアジア太平洋に区分されます。2022年には、中国セグメントがアジア太平洋の脳深部刺激療法市場で最大のシェアを記録しました。

Abbott Laboratories社、Beijing PINS Medical Co Ltd社、Boston Scientific Corp社、Medtronic Plc社、SceneRay Co Ltd社は、アジア太平洋の脳深部刺激療法市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

• 主要洞察
• アジア太平洋の脳深部刺激療法市場：地域別

第3章 調査手法

• 調査範囲
• 2次調査
• 1次調査

第4章 アジア太平洋の脳深部刺激療法市場情勢

• イントロダクション
• アジア太平洋PEST分析
• 比較分析
  • 脳深部刺激療法と病変形成手技の比較
  • 神経疾患における病変形成手順
  • 2022年に実施されるアジア太平洋の脳深部刺激療法の手術手技：国別

第5章 アジア太平洋の脳深部刺激療法市場：主要産業力学

• 主要市場の促進要因
  • 神経疾患の有病率の上昇
  • 低侵襲手術の需要
• 市場抑制要因
  • 脳深部刺激に伴う副作用
• 市場機会
  • 脳深部刺激療法における技術の進歩と承認
• 今後の動向
  • 研究開発の活発化
• 影響分析

第6章 脳深部刺激療法市場：アジア太平洋市場分析

• アジア太平洋の脳深部刺激療法市場売上高、2022～2030年

第7章 アジア太平洋の脳深部刺激療法市場：2030年までの収益と予測：製品別

• イントロダクション
• アジア太平洋の脳深部刺激療法市場：製品別、2022年・2030年売上高シェア（%）
• シングルチャネル脳深部刺激療法
• デュアルチャネル脳深部刺激療法
• ソフトウェアと付属品

第8章 アジア太平洋の脳深部刺激療法市場：用途別収益と2030年までの予測

• イントロダクション
• アジア太平洋の脳深部刺激療法市場：用途別、2022年・2030年売上高シェア（%）
• パーキンソン病
• 振戦
• アルツハイマー病
• ジストニア
• てんかん
• その他

第9章 アジア太平洋の脳深部刺激療法市場：エンドユーザー別収益と2030年までの予測

• イントロダクション
• アジア太平洋の脳深部刺激療法市場：エンドユーザー別、2022年・2030年売上高シェア（%）
• 病院
• 神経クリニック
• 外来手術センター
• その他

第10章 アジア太平洋の脳深部刺激療法市場：国別分析

• 概要
  • アジア太平洋の脳深部刺激療法市場：国別一覧
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他のアジア太平洋

第11章 COVID-19前後の影響

• COVID-19前後の影響

List Of Tables

• Table 1. Asia Pacific Deep Brain Simulation Market Segmentation
• Table 2. Comparison of Deep Brain Stimulation and Lesioning Procedures
• Table 3. Asia Pacific Deep Brain Stimulation Surgical Procedures Performed in 2022, by Country.
• Table 4. China Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
• Table 5. China Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
• Table 6. China Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
• Table 7. Japan Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
• Table 8. Japan Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
• Table 9. Japan Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
• Table 10. India Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
• Table 11. India Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
• Table 12. India Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
• Table 13. Australia Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
• Table 14. Australia Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
• Table 15. Australia Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
• Table 16. South Korea Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
• Table 17. South Korea Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
• Table 18. South Korea Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
• Table 19. Rest of Asia Pacific Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
• Table 20. Rest of Asia Pacific Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
• Table 21. Rest of Asia Pacific Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
• Table 22. Recent Organic Growth Strategies in Deep Brain Stimulation Market
• Table 23. Recent Inorganic Growth Strategies in the Asia Pacific deep brain simulation market
• Table 24. Glossary of Terms, Asia Pacific Deep Brain Simulation Market

List Of Figures

• Figure 1. Asia Pacific Deep Brain Simulation Market Segmentation, By Country
• Figure 2. Asia Pacific - PEST Analysis
• Figure 3. Asia Pacific Deep Brain Simulation Market - Key Industry Dynamics
• Figure 4. Impact Analysis of Drivers and Restraints
• Figure 5. Asia Pacific Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030
• Figure 6. Asia Pacific Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
• Figure 7. Single Channel Deep Brain Stimulator: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 8. Dual Channel Deep Brain Stimulator: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 9. Software and Accessories: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 10. Asia Pacific Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
• Figure 11. Parkinson's Disease: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 12. Tremor: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 13. Alzheimer's Disease: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 14. Dystonia: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 15. Epilepsy: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 16. Others: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 17. Asia Pacific Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
• Figure 18. Hospitals: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 19. Neurology Clinics: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 20. Ambulatory Surgical Centers: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 21. Others: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 22. Asia Pacific Deep Brain Simulation Market, By Country, 2022 ($Mn)
• Figure 23. Asia Pacific Deep Brain Simulation Market, By Key Countries, 2022 And 2030 (%)
• Figure 24. China Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
• Figure 25. Japan Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
• Figure 26. India Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
• Figure 27. Australia Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
• Figure 28. South Korea Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
• Figure 29. Rest of Asia Pacific Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
• Figure 30. Pre & Post Covid-19 Impact
• Figure 31. Growth Strategies in Deep Brain Stimulation Market

The Asia Pacific deep brain simulation market is expected to grow from US$ 98.35 million in 2022 to US$ 188.04 million by 2030. It is estimated to grow at a CAGR of 8.4% from 2022 to 2030.

Technological Advancements and Approvals in Deep Brain Stimulation Drive Asia Pacific Deep Brain Simulation Market

Robotic implantation, multi-target stimulation, improved microelectrode designs, rechargeable pulse generators, and personalized, targeted programming are among the technological advancements in deep brain stimulation (DBS). Owing to these advancements, DBS devices show fewer side effects and improved efficacy and symptom relief in Parkinson's patients compared to traditional methods. Abbott's Infinity Deep Brain Stimulation System is a technologically advanced new DBS that helps the patients manage their symptoms. It is the first wireless iOS software DBS mobile platform that has offered efficient and personalized therapy management with reduced risk of side effects. According to the MGM Healthcare press release published in February 2020, MGM Healthcare, Tamil Nadu, performed its first deep brain stimulation (DBS) for obsessive-compulsive disorder (OCD). Therefore, technological advancements in DBS are expected to create opportunities for the Asia Pacific deep brain stimulation market during the forecast period.

Asia Pacific Deep Brain Simulation Market Overview

China is home to the world's largest population of older adults. According to a study published in The Lancet titled "China's Aging Population: Crisis or Opportunity?" in 2019, people in China aged 60 or older were ~254 million. By 2040, that number is expected to rise to 402 million, ~28% of the population. These changes have profound public health implications in the country as the risk and burden of noncommunicable diseases increase along with the demand for health and social care systems. Parkinson's disease (PD) is a common neurodegenerative disease in the country. According to ChinaDaily, there were approximately 4 million Parkinson's patients in China as of February 2023, and ~1.7% of people over 65 years have been diagnosed with the disease. According to a study discussed in the Journal of Health, Population, and Nutrition, the number of people with Alzheimer's disease in China is ~6 million, with dementia rates among 65-, 75-, and 85-year-olds being 5%, 11.5%, and 30%, respectively. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is effective in the treatment of Parkinson's disease (PD). With advancements in DBS hardware, researchers have developed several novel programming technologies, of which remote programming is widely used in China. Since 2018, we have been performing remote programming for patients suffering from PD using PINS products (PINS Medical, Ltd., Beijing, China). For patients with advanced Parkinson's disease (over a 15-year time horizon), DBS is considered to be a highly effective treatment option. However, DBS remains a significant economic burden on the patient when not reimbursed, unlike in any other developed country. In China, the surgery cost is mainly covered by the patient's health insurance, but the cost of DBS hardware is only partially covered, which can hamper the growth of the market in the country.

Asia Pacific Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Deep Brain Simulation Market Segmentation

The Asia Pacific deep brain simulation market is segmented into product, application, end user, and country.

Based on product, the Asia Pacific deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the Asia Pacific deep brain simulation market.

Based on application, the Asia Pacific deep brain simulation market is segmented into Parkinson's disease, tremor, dystonia, epilepsy, Alzheimer's disease, and others. In 2022, the Parkinson's disease segment registered the largest share in the Asia Pacific deep brain simulation market.

Based on end user, the Asia Pacific deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the Asia Pacific deep brain simulation market.

Based on country, the Asia Pacific deep brain simulation market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. In 2022, China segment registered the largest share in the Asia Pacific deep brain simulation market.

Abbott Laboratories, Beijing PINS Medical Co Ltd, Boston Scientific Corp, Medtronic Plc, and SceneRay Co Ltd are some of the leading companies operating in the Asia Pacific deep brain simulation market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific deep brain simulation market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific deep brain simulation market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the deep brain simulation market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights
• 2.2 Asia Pacific Deep Brain Stimulation Market, by Region (US$ Million)

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia Pacific Deep Brain Simulation Market Landscape

• 4.1 Overview
• 4.2 Asia Pacific PEST Analysis
• 4.3 Comparison Analysis
  • 4.3.1 Comparison of Deep Brain Stimulation and Lesioning Procedures
  • 4.3.2 Lesioning Procedures in Neurological Disorders
  • 4.3.3 Asia Pacific Deep Brain Stimulation Surgical Procedures Performed in 2022, By Country

5. Asia Pacific Deep Brain Simulation Market - Key Industry Dynamics

• 5.1 Key Market Drivers:
  • 5.1.1 Rising Prevalence of Neurological Disorders
  • 5.1.2 Demand for Minimally Invasive Surgery
• 5.2 Market Restraints
  • 5.2.1 Side Effects Associated with Deep Brain Stimulation
• 5.3 Market Opportunities
  • 5.3.1 Technological Advancements and Approvals in Deep Brain Stimulation
• 5.4 Future Trends
  • 5.4.1 Growing Research and Development Activities
• 5.5 Impact Analysis

6. Deep Brain Simulation Market - Asia Pacific Market Analysis

• 6.1 Asia Pacific Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Product

• 7.1 Overview
• 7.2 Asia Pacific Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
• 7.3 Single Channel Deep Brain Stimulator
  • 7.3.1 Overview
  • 7.3.2 Single Channel Deep Brain Stimulator: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Dual Channel Deep Brain Stimulator
  • 7.4.1 Overview
  • 7.4.2 Dual Channel Deep Brain Stimulator: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Software and Accessories
  • 7.5.1 Overview
  • 7.5.2 Software and Accessories: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Application

• 8.1 Overview
• 8.2 Asia Pacific Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
• 8.3 Parkinson's Disease
  • 8.3.1 Overview
  • 8.3.2 Parkinson's Disease: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Tremor
  • 8.4.1 Overview
  • 8.4.2 Tremor: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• 8.5 Alzheimer's Disease
  • 8.5.1 Overview
  • 8.5.2 Alzheimer's Disease: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• 8.6 Dystonia
  • 8.6.1 Overview
  • 8.6.2 Dystonia: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• 8.7 Epilepsy
  • 8.7.1 Overview
  • 8.7.2 Epilepsy: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• 8.8 Others
  • 8.8.1 Overview
  • 8.8.2 Others: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 - by End User

• 9.1 Overview
• 9.2 Asia Pacific Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
• 9.3 Hospitals
  • 9.3.1 Overview
  • 9.3.2 Hospitals: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 Neurology Clinics
  • 9.4.1 Overview
  • 9.4.2 Neurology Clinics: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5 Ambulatory Surgical Centers
  • 9.5.1 Overview
  • 9.5.2 Ambulatory Surgical Centers: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: Asia Pacific Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Deep Brain Simulation Market - Country Analysis

• 10.1 Overview
  • 10.1.1.1 Asia Pacific Deep Brain Simulation Market by Country
  • 10.1.1.2 China
    • 10.1.1.2.1 Overview
    • 10.1.1.2.2 China Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.1.2.3 China Deep Brain Simulation Market, by Product
    • 10.1.1.2.4 China Deep Brain Simulation Market, by Application
    • 10.1.1.2.5 China Deep Brain Simulation Market, by End User
  • 10.1.1.3 Japan
    • 10.1.1.3.1 Overview
    • 10.1.1.3.2 Japan Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.1.3.3 Japan Deep Brain Simulation Market, by Product
    • 10.1.1.3.4 Japan Deep Brain Simulation Market, by Application
    • 10.1.1.3.5 Japan Deep Brain Simulation Market, by End User
  • 10.1.1.4 India
    • 10.1.1.4.1 Overview
    • 10.1.1.4.2 India Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.1.4.3 India Deep Brain Simulation Market, by Product
    • 10.1.1.4.4 India Deep Brain Simulation Market, by Application
    • 10.1.1.4.5 India Deep Brain Simulation Market, by End User
  • 10.1.1.5 Australia
    • 10.1.1.5.1 Overview
    • 10.1.1.5.2 Australia Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.1.5.3 Australia Deep Brain Simulation Market, by Product
    • 10.1.1.5.4 Australia Deep Brain Simulation Market, by Application
    • 10.1.1.5.5 Australia Deep Brain Simulation Market, by End User
  • 10.1.1.6 South Korea
    • 10.1.1.6.1 Overview
    • 10.1.1.6.2 South Korea Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.1.6.3 South Korea Deep Brain Simulation Market, by Product
    • 10.1.1.6.4 South Korea Deep Brain Simulation Market, by Application
    • 10.1.1.6.5 South Korea Deep Brain Simulation Market, by End User
  • 10.1.1.7 Rest of Asia Pacific
    • 10.1.1.7.1 Overview
    • 10.1.1.7.2 Rest of Asia Pacific Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.1.7.3 Rest of Asia Pacific Deep Brain Simulation Market, by Product
    • 10.1.1.7.4 Rest of Asia Pacific Deep Brain Simulation Market, by Application
    • 10.1.1.7.5 Rest of Asia Pacific Deep Brain Simulation Market, by End User

11. Pre & Post Covid-19 Impact

• 11.1 Pre & Post Covid-19 Impact

12. Asia Pacific Deep Brain Simulation Market Industry Landscape

• 12.1 Overview
• 12.2 Growth Strategies in Deep Brain Stimulation Market
• 12.3 Organic Growth Strategies
  • 12.3.1 Overview
• 12.4 Inorganic Growth Strategies
  • 12.4.1 Overview

13. Deep Brain Simulation Market, Key Company Profiles

• 13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 Medtronic Plc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 Beijing PINS Medical Co Ltd
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 Boston Scientific Corp
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 SceneRay Co Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments

14. Appendix

• 14.1 About Us
• 14.2 Glossary of Terms